Vaishali Shukla

Vaishali Shukla, PhD, is Vice President of Cell & Gene Therapy and API Global Expansion at Eli Lilly and Company, where she leads global efforts to scale advanced therapy manufacturing and supply networks. With more than 20 years of experience in the biopharmaceutical industry, she has worked across areas including early clinical development through commercialization of cell and gene therapies, biologics, peptides, ADCs, and small molecules. In her current role, Vaishali oversees strategy for API and CGT manufacturing expansion and plays a key role in enabling the global delivery of advanced therapies with quality and consistency.